MindPortal

London, UKFounded 20191–10 employeesmindportal.comLinkedIn

Brain-computer interfaces

MindPortal is an AI research lab focused on creating new interfaces between people and AI, including neural interfaces and thought-based AI models. It tackles difficult human-AI interaction problems with specialist teams, develops working systems, and protects its innovations through intellectual property.

Visit mindportal.com ↗

Founded: 2019
Employees: 1–10

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

MindPortal’s public milestones point to work spanning non-invasive brain-computer interfaces, imagined-speech processing, and AI interaction. On Dec 10, 2023, coverage described an optical interface connecting brain signals with AI, including ChatGPT; this indicates a public demonstration or research milestone, not proof of broad commercial deployment. A Oct 17, 2023 article also discussed the physics of brain-computer interfaces. Patent-related timeline entries include publications dated Mar 18, 2024, Apr 4, 2024, and Sep 10, 2024 covering brain-computer interface data processing, user-intention determination, and extended-reality or eye-tracking applications. Two further entries dated Jun 23, 2025 concern neural interfaces and processing imagined sentences. MindPortal’s listed product concepts include MindSpeech, described as converting continuous imagined speech into text without surgery, and a non-invasive neural interface device. The company raised a $5 million seed round on May 24, 2021, led by Learn Capital.

Market position

MindPortal operates at the intersection of neuroscience, health diagnostics, wearables, and AI, with a focus on non-invasive neural interfaces and thought-based interaction. Its listed MindSpeech product targets continuous imagined-speech decoding, while its wearable device concept aims to capture brain signals for interaction with AI. These product descriptions distinguish its stated focus from broader health-monitoring wearables, but there is not enough evidence here to assess product performance, clinical validation, or commercial adoption. The company’s categories place it alongside both neuroscience research and health diagnostics rather than positioning it solely as a consumer electronics business. Its $5 million seed financing, completed in 2021 with Learn Capital as lead investor, and team size below 10 indicate a small, early-stage operation. Its potential differentiation rests on imagined-speech decoding and neural-signal capture without surgery; whether these capabilities translate into a defensible market advantage remains unverified.

Growth & opportunities

MindPortal’s trajectory shows a long research and development horizon with limited disclosed financing and a lean team. The company was founded in 2019, raised a pre-seed round on Jun 5, 2020 with no amount stated, and completed a $5 million seed round on May 24, 2021 led by Learn Capital. The seed round is the latest funding event listed, so the available financing history does not establish a later acceleration or new capital inflection. Public milestones suggest continued technical activity after that raise: coverage in October and December 2023 addressed brain-computer interfaces and thought-based AI interaction, while patent-related timeline entries dated 2024 and 2025 describe work involving neural interfaces, signal processing, imagined sentences, and user intentions. MindSpeech is described as a model for converting imagined speech into text, but no launch date, customer traction, or commercialization figures are provided. The reported team size remains below 10, and there is no stated recent hiring or layoff activity. Overall, the evidence indicates ongoing technical development, but not enough information to quantify growth in revenue, headcount, or market adoption.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes MindPortal distinct

reccy insights

What makes MindPortal distinct

01Focuses on neural interfaces and thought-based approaches to human-AI interaction.
02Develops non-invasive wearable concepts for capturing brain signals.
03Describes MindSpeech as a model for converting continuous imagined speech into text.
04Uses specialist teams focused on specific challenges and working systems.
05Combines AI architectures, hardware optimization, proprietary datasets, and trade secrets as elements of its intellectual-property strategy.

Technology & products2

Technology & products

MindSpeech
An AI model that converts continuous imagined speech from the brain into text without requiring surgery.
Non-invasive Neural Interface Device
A wearable device designed to capture brain signals without surgery and enable communication between people and AI.

MindSpeech, an imagined-speech-to-text AI model.
Neural network designs for thought decoding.
Methods for enhancing neural-signal capture and processing.
Training paradigms and data-collection methods for neural interfaces.
A non-invasive wearable neural interface concept for AI interaction.

Similar companies

Show all 6 companies

About MindPortal

Products: MindSpeech, Non-invasive Neural Interface Device
Leadership: Ekram Alam, Co-founder / CEOJack Baber, Co-founder & CTO
Focus areas: NeuroTechnology, AI/ML, research tools, hardware, health diagnostics, neuroscience, wearables
Headquarters: London, UK
Founded: 2019
Employees: 1–10